Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Microelimination"'
Autor:
Chung‐Feng Huang, Tyng‐Yuan Jang, Shun‐Chieh Yu, Shin‐Chung Huang, Shao‐Lun Ho, Ming‐Lun Yeh, Chih‐Wen Wang, Po‐Cheng Liang, Yu‐Ju Wei, Po‐Yao Hsu, Ching‐I Huang, Ming‐Yen Hsieh, Yi‐Hung Lin, Sung‐Lin Yu, Pey‐Fang Wu, Yu‐Han Chen, Shin‐Chi Chien, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Tso‐Jen Wang, Ming‐Lung Yu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 1, Pp 86-93 (2024)
Abstract Patients with serious mental illness have a higher risk of hepatitis C virus (HCV) infection but suboptimal HCV care. The current study aimed to facilitate HCV treatment uptake by implementing an integrated outreach care model. Multidiscipli
Externí odkaz:
https://doaj.org/article/5bccbb53c9844936b00c4005a9e34370
Autor:
Cheng-Hung Chien, Tien-Shin Chou, Li-Wei Chen, Chih-Lang Lin, Jia-Jang Chang, Ching-Jung Liu, Shuo-Wei Chen, Ching-Chih Hu, Rong-Nan Chien
Publikováno v:
Microorganisms, Vol 12, Iss 7, p 1402 (2024)
The optimal strategy for the microelimination of HCV within community settings remains ambiguous. We evaluated the percentage of participants who achieved linkage to care (LTC) following the conclusion of a screening campaign and examined the diverse
Externí odkaz:
https://doaj.org/article/98f806ad13424c5e9f816993b49215ef
Autor:
Miao-Hui Huang, Guan-Jhou Chen, Hsin-Yun Sun, Yi-Ting Chen, Li-Hsin Su, Shu-Yuan Ho, Sui-Yuan Chang, Sung-Hsi Huang, Yi-Chia Huang, Wang-Da Liu, Kuan-Yin Lin, Yu-Shan Huang, Yi-Ching Su, Wen-Chun Liu, Chien-Ching Hung
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 3, Pp 566-574 (2023)
Background: Understanding the risk behaviors associated with sexually-transmitted hepatitis C virus (HCV) infection among men who have sex with men (MSM) may inform the public health policies and interventions aiming to achieve HCV microelimination.
Externí odkaz:
https://doaj.org/article/4c5eb666553b4453bbb7d4100c00f2bb
Autor:
Ching-I Huang, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Ming-Yen Hsieh, Ta-Wei Liu, Yi-Hung Lin, Meng-Hsuan Hsieh, Tyng-Yuan Jang, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung Yu
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 3, Pp 586-597 (2023)
Objectives: Gaps in linkage-to-care remain the barriers toward hepatitis C virus (HCV) elimination in the directly-acting-antivirals (DAA) era, especially during SARS Co–V2 pandemics. We established an outreach project to target HCV micro-eliminati
Externí odkaz:
https://doaj.org/article/ca655321d3d347789df7020ea97abbc9
Autor:
Diana Corona-Mata, Antonio Rivero-Juárez, Ángela Camacho, Laura Ruiz-Torres, Inmaculada Ruiz-Cáceres, Bartolomé de la Fuente Darder, David Cáceres-Anillo, María de Guía Castro-Granados, María Lizaur-Barbudo, María Victoria Cabrera-Gisbert, Justa Redondo-Écija, Ana Aparicio-Aparicio, Leticia Manchado-López, Luciano Cobos, Ignacio Pérez-Valero, Antonio Rivero
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Background and aimsThe burden hepatitis C infection in people with history or current drug use suppose a high risk of hepatic complications and transmission infectious disease. This population is poor linked to heath system and is difficult to achiev
Externí odkaz:
https://doaj.org/article/4deb26adb6d64c38a65a66aac86dd591
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Walaa M. Hashem, Manal Hamdy El-Sayed, Ossama A. Ahmed, Hany M. Dabbous, Mohamed Kamal Shaker, Ahmed Fouad Sherief, Mary Gamal Naguib, Shereen Abdel-Monem Ibrahim, Ahmed Mansour
Publikováno v:
Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Background Patients with chronic hemolytic anemias (CHA) are at a high risk for transfusion-transmitted infections. Various studies in Egypt have shown a prevalence of hepatitis C virus (HCV) infection in 24–37% of those patients. Eliminat
Externí odkaz:
https://doaj.org/article/38f8a41ab52d4c02a820835464ebb522
Autor:
Hsin-Yun Sun, Chieh Chiang, Sung-Hsi Huang, Wen-Jin Guo, Yu-Chung Chuang, Yi-Chia Huang, Chia-Jui Yang, Li-Hsin Su, Yi-Ting Chen, Yea-Wen Chen, Fu-Chiang Hsu, Shu-Yuan Ho, Wen-Chun Liu, Yi-Ching Su, Sui-Yuan Chang, Chin-Fu Hsiao, Chien-Ching Hung, Ming-Lung Yu
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Timely diagnosis and treatment of hepatitis C virus (HCV) infection may prevent its transmission. We evaluated the performance and cost reductions of the pooled plasma HCV RNA testing strategy to identify acute HCV infections among people li
Externí odkaz:
https://doaj.org/article/78533af05efd4850a6ddba663dcc7588
Autor:
Britt Skaathun, Annick Borquez, Antonio Rivero-Juarez, Sanjay R. Mehta, Francisco Tellez, Manuel Castaño-Carracedo, Dolores Merino, Rosario Palacios, Juan Macías, Antonio Rivero, Natasha K. Martin
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Scale-up of hepatitis C virus (HCV) treatment for HIV/HCV coinfected individuals is occurring in Spain, the vast majority (> 85%) with a reported history of injecting drug use and a smaller population of co-infected men who have s
Externí odkaz:
https://doaj.org/article/d7363b8cda9244fa804efb55afea3f0b
Autor:
Radha K. Dhiman, MD, DM, FAMS, FACG, FRCP, FAASLD, Gagandeep S. Grover, MD, Madhumita Premkumar, MD, DM, Akash Roy, MD, DM, Sunil Taneja, MD, DM, Ajay Duseja, MD, DM, FAMS, FACG, FAASLD, Sanjeev Arora, MD
Publikováno v:
EClinicalMedicine, Vol 41, Iss , Pp 101148- (2021)
Background: The prevalence of chronic hepatitis C (CHC) in People Who Inject Drugs (PWID) is 8-10% as compared to 3·6% in the general population in Punjab, India. We assessed the real-world efficacy and safety of free-of-charge generic direct-acting
Externí odkaz:
https://doaj.org/article/aaef033623a94e98956a70f3060430ef